The effect of Oleoyl ethanolamide (OEA) supplementation in patients with acute ischemic brain stroke
Phase 2
- Conditions
- Acute ischemic brain stroke.Cerebral infarction, unspecifiedI63.9
- Registration Number
- IRCT20130501013194N4
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Willingness to cooperate
Acute ischemic brain stroke (preferably under one month)
Exclusion Criteria
taking immunosuppressive drugs
History of rheumatic and collagenvascular diseases
History of recent infections (within 2 to 3 months)
Swallowing disorders that are unable to take medication
Sensitivity to compounds
No regular use of supplements
Not willing to cooperate
Diabetes
kidney disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method